3.8 Article

Oculopharyngeal muscular dystrophy coexisting with myasthenia gravis

Journal

PRACTICAL NEUROLOGY
Volume 22, Issue 5, Pages 413-+

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/practneurol-2022-003429

Keywords

-

Ask authors/readers for more resources

This article reports a patient with atypical oculopharyngeal muscular dystrophy and acetylcholine receptor antibody-mediated myasthenia gravis, highlighting the importance of the association between myasthenia gravis and genetic myopathies in terms of diagnosis and treatment.
Oculopharyngeal muscular dystrophy (OPMD) and myasthenia gravis are both rare conditions of different pathophysiological nature, so a fortuitous association is unlikely. However, antiacetylcholine receptor antibodies may be found in other genetic myopathies and this is probably not coincidental. Muscle fibre degeneration can induce innate immune responses that may break immune tolerance and allow the generation of autoantibodies to muscle proteins. We report a patient with atypical OPMD who also had acetylcholine receptor antibody-mediated myasthenia gravis. This report raises awareness of the diagnostic and treatment implications of the association of myasthenia gravis with genetic myopathies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available